CDK9 and colorectal carcinoma: Consequently, CDK9 inhibitor treatment resulted in escalated SL and decreased cell proliferation in the APC-deficient CRC cells, facilitating the targeted elimination of CRC cells at the cellular level (Fig. 1P).